Most ATCs harbor mutations that activate one of two pathways that act as drivers of the transformation process: the RAS/BRAF/MAPK cascade, and the PI3K/PTEN/AKT cascade [47]. The gene discussed is PTEN; the disease is Ehlers-Danlos syndrome, musculocontractural type.